<DOC>
	<DOCNO>NCT02516904</DOCNO>
	<brief_summary>A single ascending dose study evaluate safety , tolerability , pharmacokinetics CD101 IV</brief_summary>
	<brief_title>A Single Ascending Dose Study CD101 IV Healthy Subjects</brief_title>
	<detailed_description>This Phase 1 , single-center , prospective , randomize , double-blind study ascend single dos CD101 Injection administer IV healthy adult subject . In study , subject 4 cohort 8 subject , randomize receive single IV dose CD101 Injection placebo . Dose level CD101 assess follow ascend single-dose regimen .</detailed_description>
	<criteria>Males surgically sterilize use contraception , No significant finding physical , ECG , clinical laboratory test , BMI 18.5 32.0 , Must provide informed consent Females child bear potential , Signs symptoms acute chronic illness , Use prescription medication within 28 day , Use OTC , supplement , herbal within 14 day , Current smoker Previous participation clinical study within 28 day</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Subjects</keyword>
</DOC>